Poster: Liver transplantation and hepatobiliary surgery: Clinical aspects

 General hepatology
 Liver transplant and surgery

Poster Area

Poster
12 April 2019 09:00 - 17:00


Presentations

Title Time Appointment Abstract
FRI-361 Impact of cardiovascular complications on patients' outcome after orthotopic liver transplantation
12 April 2019 09:00 - 17:00
FRI-362 Exercise training for liver transplant candidates
12 April 2019 09:00 - 17:00
FRI-363 Iron metabolism imbalance is associated with increased mortality following orthotopic liver transplantation
12 April 2019 09:00 - 17:00
FRI-364 Frequency and impact of discordance between pre-transplant imaging and explant histology on post liver transplant outcomes for patients with hepatocellular carcinoma
12 April 2019 09:00 - 17:00
FRI-365 Efficacy of combined partial hepatectomy and cyst fenestration on health-related quality of life in polycystic liver disease
12 April 2019 09:00 - 17:00
FRI-366 Portal vein thrombosis in patients on the waiting list for liver transplantation: A single center cohort study
12 April 2019 09:00 - 17:00
FRI-367 Pre-liver transplant profile of cardiovascular risk factors and its impact on early post-transplant outcome
12 April 2019 09:00 - 17:00
FRI-369 The role of adipose tissue in metabolic and cardiovascular complication after liver transplantation
12 April 2019 09:00 - 17:00
FRI-370 Application of an extended-release tacrolimus formulation allows dose reduction and stabilizes graft function after liver transplantation
12 April 2019 09:00 - 17:00
FRI-371 Correlation between classification of circulating tumor cells in peripheral blood and early recurrence in patients with hepatocellular carcinoma after liver transplantation
12 April 2019 09:00 - 17:00
FRI-372 Next generation sequenzing outperforms standard microbiological cultivation for detection of bacteria in the biliary tract in patients with ischemic type biliary lesions and/or anastomotic stricture
12 April 2019 09:00 - 17:00
FRI-373 Mismatch in C-locus Eplets between donor and recipient as independent factor of acute T-cell mediated rejection in liver transplantation
12 April 2019 09:00 - 17:00
FRI-374 Von Willebrand factor independently predicts mortality on the waitlist for liver transplantation and facilitates additional risk stratification in low MELD patients
12 April 2019 09:00 - 17:00
FRI-375 Direct oral anticoagulants are safe and effective in patients after liver/kidney transplantation
12 April 2019 09:00 - 17:00
FRI-376 Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
12 April 2019 09:00 - 17:00
FRI-377 Survival outcome after liver transplantation in US patients with hepatocellular carcinoma
12 April 2019 09:00 - 17:00
FRI-378 Should we change the allocation policy for NASH patients?
12 April 2019 09:00 - 17:00
FRI-379 Renal dysfunction between tenofovir and entecavir in patients with hepatitis B virus after liver transplantation
12 April 2019 09:00 - 17:00
FRI-380 Factors and models for predicting posthepatectomy liver failure in patients undergoing hepatic resection for hepatocellular carcinoma
12 April 2019 09:00 - 17:00
FRI-381 Latent trajectory analysis of serum creatinine in patients with end stage liver disease: Predictors of pre- and post-transplant outcomes
12 April 2019 09:00 - 17:00
FRI-382 Biological assessment comprising alpha-fetoprotein, albumin-bilirubin score and C-reactive protein provides better prognostic competence than tumor size criteria in liver transplant patients with HCC
12 April 2019 09:00 - 17:00
FRI-383 Role of traditional cardiovascular risk factors in predicting long term survival after liver transplantation
12 April 2019 09:00 - 17:00
FRI-384 Early cardiovascular mortality following liver transplantation: 30-year temporal trends from the Australian & New Zealand liver transplant registry
12 April 2019 09:00 - 17:00
FRI-385 Use of machine learning algorithms to predict HCC recurrence after liver transplantation: A proof of concept
12 April 2019 09:00 - 17:00
FRI-386 Impact of acute-on-chronic liver failure on survival after liver transplantation
12 April 2019 09:00 - 17:00
FRI-387 Risk factors associated with early post-operative acute kidney injury requiring renal replacement therapy following liver transplantation
12 April 2019 09:00 - 17:00
FRI-388 Hepatitis C iInfected liver grafts transplanted into non-infected recipients are safe in the era of highly effective direct-acting antiviral therapy
12 April 2019 09:00 - 17:00
FRI-389 Impact of coronary artery disease on long term mortality after liver transplantation
12 April 2019 09:00 - 17:00
FRI-390 Management of dyslipidemia after liver transplantation
12 April 2019 09:00 - 17:00
FRI-391 Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are markers for biliary damage and predict graft survival
12 April 2019 09:00 - 17:00
FRI-392 Sarcopenia associated with worse pre-transplant psychosocial status and predicted post-transplant diabetes
12 April 2019 09:00 - 17:00
FRI-393 Arterial stiffness in the assessment of cardiovascular risk after liver transplantation
12 April 2019 09:00 - 17:00
FRI-394 Impact of early kidney dysfunction in the incidence of major cardiovascular events after liver transplantation
12 April 2019 09:00 - 17:00
FRI-395 Etiology of liver disease affects weight gain after liver transplantation
12 April 2019 09:00 - 17:00
FRI-396 Hypoadiponectinemia as a predictor of cardiovascular events in liver transplant recipients
12 April 2019 09:00 - 17:00
FRI-397 Sepsis is a major risk factor for delirium post liver transplantation
12 April 2019 09:00 - 17:00
FRI-398 Impact of sarcopenia and myosteatosis on post-transplant complications and survival
12 April 2019 09:00 - 17:00
FRI-399 Impact of a temporary cardiac arrest in a brain dead liver donor on liver transplantation results
12 April 2019 09:00 - 17:00
FRI-400 Poor long term outcome of patients undergoing liver transplantation with preterminal renal dysfunction
12 April 2019 09:00 - 17:00
FRI-401 Direct-acting antiviral agents are not associated with an increased risk of hepatocellular carcinoma recurrence in liver transplant recipients with hepatitis C
12 April 2019 09:00 - 17:00
FRI-402 Outcomes after liver transplantation for argininosuccinate lyase deficiency: A longitudinal study
12 April 2019 09:00 - 17:00
FRI-403 Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome
12 April 2019 09:00 - 17:00
FRI-404 Multicenter experience evaluating outcomes of HCV-seropositive donors to HCV-seronegative recipients liver transplantation
12 April 2019 09:00 - 17:00
FRI-405 Predictors of outcomes for patients with non-alcoholic steatohepatitis undergoing liver transplantation in the United States
12 April 2019 09:00 - 17:00